$138.780
+0.291 (+0.21%)Zum Schluss
MANE im Vergleich zur Peergroup
In the context of the broader market, MANE competes directly with industry leaders such as TVTX and ERAS. With a market capitalization of $5.80B, it holds a leading position in the sector. When comparing efficiency, MANE's gross margin of N/A stands against TVTX's 96.45% and ERAS's N/A. Such benchmarking helps identify whether Veradermics, Incorporated is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Veradermics Inc
The company has shown a significant increase in total equity, from -122,863,000 USD in Q4 2025 to 813,613,000 USD in Q2 2026, indicating a strong recovery in financial health despite ongoing net losses.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.